1. Mortality and cardiovascular risk in vasculitis ANCA. Importance of hypertension and renal function. Experience from southern Spain.
- Author
-
Martin-Gómez MA, Rodríguez Torres A, Espinosa Hernández M, Lopez Mendoza M, Sabio Sánchez JM, Martin Armada M, Martin Suarez I, Callejas Rubio JL, Castilla Castellano MM, Anglada Pintado JC, Barnosi Marín AC, Martinez Esteban MD, Castilla Guerra L, and De Ramón Garrido E
- Subjects
- Humans, Antibodies, Antineutrophil Cytoplasmic, Heart Disease Risk Factors, Kidney, Retrospective Studies, Risk Factors, Spain epidemiology, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis complications, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis diagnosis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis epidemiology, Cardiovascular Diseases epidemiology, Cardiovascular Diseases etiology, Hypertension complications, Hypertension epidemiology
- Abstract
Background: Cardiovascular disease (CVD) is one of the principal causes of death in antineutrophil cytoplasmic antibody-(ANCA)-associated vasculitis (AAV)., Objectives: To evaluate the mortality and it's causes and CVD and its vascular risk factors (VRFs) in AAV patients in Andalusia., Methods: A multicenter cohort of 220 AAV patients followed-up from 1979 until June 2020 was studied in Andalussia, south of Spain. The information, including socio-demographic and clinical data was recorded retrospectively through chart review. Data was analysed using Chi
2 , ANOVA and Cox proportional hazards regresion as uni and multivariate test with a 95% confidence interval (CI)., Results: During a mean ± standard deviation follow-up of 96.79 ± 75.83 months, 51 patients died and 30 presented at least one CVE. Independent prognostic factors of mortality were age (HR 1.083, p=0.001) and baseline creatinine (HR 4.41, p=0.01). Independent prognostic factors of CVE were age [hazard ratio (HR) 1.042, p=0.005] and the presence of hypertension (HTN) six months after diagnosis (HR 4.641, p=0.01). HTN, diabetes and renal failure, all of these important VRFs, are more prevalent in AAV patients than it is described in matched general population., Conclusions: Age and baseline renal function, but not CVEs, are predictors of mortality and age and early HTN are independent predictors for having a CVE. CVD screening in AAV patients is demanded., (Copyright © 2023 SEH-LELHA. Publicado por Elsevier España, S.L.U. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF